Kilitch Drugs | Income Statement
Fiscal year is April-March. All values INR Thousands.
2014
2015
2016
2017
2018
2019
Sales/Revenue
141,284.00
183,456.00
203,473.00
272,551.00
510,118.00
824,899
Cost of Goods Sold (COGS) incl. D&A
132,674.00
145,875.00
259,164.00
283,489.00
323,424.00
555,029
Gross Income
8,610.00
37,581.00
55,691.00
10,938.00
186,694.00
269,870
SG&A Expense
66,757.00
62,748.00
70,781.00
106,855.00
154,321.00
220,253
EBIT
58,147.00
32,685.00
145,001.00
112,806.00
32,373.00
49,617
Unusual Expense
965.00
4,497.00
2,528.00
48.00
-
-
Non Operating Income/Expense
67,876.00
23,691.00
30,500.00
1,319.00
28,754.00
40,040
Interest Expense
-
507.00
631.00
1,553.00
-
3,791
Pretax Income
10,630.00
9,484.00
116,287.00
114,140.00
61,127.00
85,866
Income Tax
1,135.00
6,590.00
4,378.00
5,633.00
9,603.00
47,568
Consolidated Net Income
11,765.00
2,894.00
111,909.00
108,507.00
51,524.00
38,298
Net Income
11,765.00
2,894.00
111,909.00
108,507.00
51,524.00
38,298
Net Income After Extraordinaries
11,765.00
2,894.00
111,909.00
108,507.00
51,524.00
38,298
Net Income Available to Common
11,765.00
2,894.00
111,909.00
108,507.00
51,524.00
38,298
EPS (Basic)
0.89
0.22
8.46
8.20
3.89
2.61
Basic Shares Outstanding
13,231.80
13,231.80
13,231.30
13,231.30
-
-
EPS (Diluted)
0.89
0.22
8.46
8.20
-
-
Diluted Shares Outstanding
13,231.80
13,231.80
13,231.30
13,231.30
-
-
EBITDA
43,750.00
14,060.00
44,355.00
15,084.00
52,797.00
70,128
Other Operating Expense
-
7,518.00
18,529.00
4,987.00
-
-
Non-Operating Interest Income
1,866.00
4,514.00
1,373.00
1,630.00
-
-
Equity in Affiliates (Pretax)
-
-
-
44.00
-
-
About Kilitch Drugs
View Profile
